JJ
Jeffrey M Jonas

Jeffrey M Jonas insider trades: Karuna Therapeutics (KRTX) stock buys and sales

Karuna Therapeutics Last trade Sep 1, 2023 56 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2014
5
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 1, 2023KRTX↓ Sell$2.6M
Aug 1, 2023KRTX↓ Sell$2.7M
Jul 3, 2023KRTX↓ Sell$3.0M
Feb 10, 2023SAGE↓ Sell$519K
Dec 9, 2019SAGE↑ Buy$482K
May 29, 2019SAGE↓ Sell$15.0M
May 24, 2019SAGE↓ Sell$16.5M
Dec 22, 2017SAGE↓ Sell$35.1M
Dec 31, 2015SAGE↑ Buy$11K
Jul 23, 2015SAGE↓ Sell$230K
Jun 16, 2015SAGE↓ Sell$15.4M
Jul 23, 2014SAGE↑ Buy$108K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jeffrey M Jonas's insider trades

Jeffrey M Jonas is an insider at Karuna Therapeutics (KRTX). Since Jul 23, 2014, Jeffrey has reported 3 open-market purchases worth $601K and 9 sales worth $90.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (34 filings), option exercises (18 filings), shares withheld for taxes (5 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.